Search Videos and More
Physician Referral Guide: Liver Tumor Clinic
THE UCSF LIVER TUMOR CLINIC provides specialized multidisciplinary care for patients with early- and intermediate-stage liver cancer and benign liver tumors.How Hungry Fat Cells Could Someday Starve Cancer to Death
Scientists transformed energy-storing white fat cells into calorie-burning ‘beige’ fat.Inhaling Cannabis May Greatly Increase Your Risk of Lung Disease
A new study in the Journal of General Internal Medicine by researchers at UC San Francisco, found that inhaling marijuana every day is associated with a 44% increased chance of developing asthma.Memory and Cognitive Disorders: The Latest Prevention, Diagnostic and Treatment Strategies
In this webinar, behavioral neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, discusses Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease dementia (PDD) and dementia with Lewy body disease (DLB).UCSF-led Clinical Trial of Patients with Juvenile Arthritis-associated Uveitis Validates Continued Treatment with Adalimumab
In a study published last January in The Lancet, UCSF researchers sought to assess efficacy and safety of discontinuing treatment in patients with juvenile idiopathic arthritis-associated uveitis by conducting a multicenter, randomized-controlled trial at twenty ophthalmology and rheumatology clinics across the U.S., the United Kingdom, and Australia.Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.Prominent Orthopaedic Surgeon and Researcher to Lead UCSF Orthopaedics Program
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma assumed his new role on January 1, 2024.Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco.One Gene Variant Is Poised to Cure Devastating COPA Syndrome
Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.AI in Cancer Care, Targeted Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat cancers and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required.Using AI to Improve Detection of Rare Diseases
Acute hepatic porphyria (AHP) is a rare genetic disease with symptoms that overlap with many other conditions, making it extremely challenging to diagnose. Its symptoms mostly affect women with severe, sometimes life-threatening attacks that include abdominal pain, nausea, vomiting, limb weakness and anxiety.Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.UCSF Among First in U.S. to Receive New Pulmonary Care Designation
UCSF has been designated a Bronchiectasis and NTM Care Center, based on the depth and breadth of its services.How We Could Test for Unhealthy Alcohol Use Before It's Too Late
A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.Gender Affirming Care, Perinatal Innovation Among Obstetrics and Gynecology Conference Talks
Innovations in perinatal care, gender affirming care and improving pregnancy outcomes for women with fibroids, were among the topics UCSF clinicians discussed at the American College of Obstetricians and Gynecologists (ACOG) 2024 Annual Clinical & Scientific MeetingStephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.The UCSF Breast Care Center
The UCSF Breast Care Center delivers integrated patient care from diagnosis through treatment and beyond at six locations across the Bay Area.Targeted Therapies, Improved Breast Cancer Screening Among Conference Presentations
UCSF’s Eric J. Small, MD, gives conference opening address as ASCO president.UCSF500 Cancer Gene Panel Test
The UCSF500 Cancer Gene Panel leverages world-class expertise for advanced cancer cases. Designed by our leading cancer specialists, the UCSF500 offers unparalleled depth and precision in genetic analysis.Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.